Company · CIK 0001815442 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Kymera Therapeutics, Inc. · KYMR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 4, 6:00 pm EDT | Brian AdamsChief Legal Officer | 6,371 | $116.83 | $744,297 | 50,254 | −11.3% | |
| Jul 27, 2026 AForm 4 → | Jul 27, 6:34 pm EDT | Terence RooneyChief Medical Officer | 38,000 | — | — | 38,000 | — | |
| Jul 7, 2026 SForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | $119.00 | $5,950,000 | 666,568 | −6.98% | 10b5-1 |
| Jul 7, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | $2.08 | $104,000 | 716,568 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Noah GoodmanChief Business Officer | 3,389 | $114.29 | $387,329 | 47,179 | −6.70% | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | $115.29 | $9,223,527 | 666,568 | −10.7% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | $2.08 | $166,400 | 746,568 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 77,109 | $114.96 | $8,864,829 | 244,883 | −23.9% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 61,378 | $5.33 | $327,145 | 321,992 | — | 10b5-1 |
| Jun 29, 2026 SForm 4/A → | Jul 2, 5:39 pm EDT | Bruce BoothDirector | 76,650 | $108.05 | $8,281,905 | 462,856 | −14.2% | 10b5-1 |
| Jun 29, 2026 SForm 4 → | Jun 30, 5:32 pm EDT | Bruce BoothDirector | 31,283 | $109.48 | $3,424,800 | 461,794 | −6.34% | 10b5-1 amended |
| Jun 26, 2026 SForm 4 → | Jun 30, 5:30 pm EDT | Bruce BoothDirector | 513,245 | $110.01 | $56,460,136 | 466,077 | −52.4% | 10b5-1 |
| Jun 26, 2026 SForm 4 → | Jun 26, 6:48 pm EDT | BVF PARTNERS L P/IL +9Director | 1,630,658 | $106.50 | $173,665,077 | 78,787 | −95.4% | |
| Jun 25, 2026 SForm 4 → | Jun 25, 9:56 pm EDT | Bruce BoothDirector | 285,684 | $121.86 | $34,812,909 | 529,718 | −35.0% | 10b5-1 |
| Jun 25, 2026 SForm 4 → | Jun 25, 6:00 pm EDT | Noah GoodmanChief Business Officer | 5,000 | $114.00 | $570,000 | 50,195 | −9.06% | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 25, 6:00 pm EDT | Noah GoodmanChief Business Officer | 5,000 | $21.05 | $105,250 | 55,195 | — | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 25, 9:55 pm EDT | Bruce BoothDirector | 398,765 | $110.31 | $43,987,355 | 564,668 | −41.4% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 22, 9:02 pm EDT | Bruce BoothDirector | 31,798 | $103.75 | $3,299,037 | 613,762 | −4.93% | 10b5-1 |
| Jun 22, 2026 SForm 4 → | Jun 22, 5:47 pm EDT | Noah GoodmanChief Business Officer | 2,500 | $99.00 | $247,500 | 50,195 | −4.74% | 10b5-1 |
| Jun 22, 2026 MForm 4 → | Jun 22, 5:47 pm EDT | Noah GoodmanChief Business Officer | 2,500 | $21.05 | $52,625 | 52,695 | — | 10b5-1 |
| Jun 17, 2026 SForm 4 → | Jun 22, 9:01 pm EDT | Bruce BoothDirector | 478,198 | $94.72 | $45,293,294 | 617,663 | −43.6% | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 9:01 pm EDT | Bruce BoothDirector | 11,741 | $20.00 | $234,820 | 11,741 | — | 10b5-1 |
| Jun 2, 2026 MForm 4 → | Jun 3, 7:30 am EDT | Bruce N. JacobsChief Financial Officer | 12,653 | $2.08 | $26,318 | 260,241 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 27, 2026 AForm 4 → | Jul 27, 6:34 pm EDT | Terence RooneyChief Medical Officer | 76,000 | — | — | 76,000 | — | |
| Jul 7, 2026 MForm 4 → | Jul 7, 8:00 pm EDT | Nello MainolfiChief Executive Officer, Director | 50,000 | — | — | 14,284 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Nello MainolfiChief Executive Officer, Director | 80,000 | — | — | 135,559 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 6:30 pm EDT | Bruce N. JacobsChief Financial Officer | 61,378 | — | — | 0 | — | 10b5-1 |
| Jun 25, 2026 MForm 4 → | Jun 25, 6:00 pm EDT | Noah GoodmanChief Business Officer | 5,000 | — | — | 90,000 | — | 10b5-1 |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:58 pm EDT | BVF PARTNERS L P/IL +9Director | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Bruce BoothDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Gorjan HrustanovicDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Jeffrey W. AlbersDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Elena RidloffDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Victor SandorDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | Pamela EspositoDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 6:00 pm EDT | John MaraganoreDirector | 6,068 | — | — | 6,068 | — | |
| Jun 24, 2026 AForm 4 → | Jun 25, 5:10 pm EDT | BAKER BROS. ADVISORS LP +5Director, 10% Owner | 12,136 | — | — | 6,068 | — | |
| Jun 22, 2026 MForm 4 → | Jun 22, 5:47 pm EDT | Noah GoodmanChief Business Officer | 2,500 | — | — | 95,000 | — | 10b5-1 |
| Jun 17, 2026 MForm 4 → | Jun 22, 9:01 pm EDT | Bruce BoothDirector | 11,741 | — | — | 28,127 | — | 10b5-1 |
| Jun 2, 2026 MForm 4 → | Jun 3, 7:30 am EDT | Bruce N. JacobsChief Financial Officer | 12,653 | — | — | 0 | — |